These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34446275)

  • 1. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause.
    Robeva R; Mladenović D; Vesković M; Hrnčić D; Bjekić-Macut J; Stanojlović O; Livadas S; Yildiz BO; Macut D
    Maturitas; 2021 Sep; 151():22-30. PubMed ID: 34446275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives.
    Venetsanaki V; Polyzos SA
    Curr Vasc Pharmacol; 2019; 17(6):546-555. PubMed ID: 29992886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease.
    Polyzos SA; Lambrinoudaki I; Goulis DG
    Hormones (Athens); 2022 Sep; 21(3):375-381. PubMed ID: 35532850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?
    Targher G; Rossini M; Lonardo A
    Endocrine; 2016 Feb; 51(2):211-21. PubMed ID: 26024975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
    Paschou SA; Polyzos SA; Anagnostis P; Goulis DG; Kanaka-Gantenbein C; Lambrinoudaki I; Georgopoulos NA; Vryonidou A
    Endocrine; 2020 Jan; 67(1):1-8. PubMed ID: 31538291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome.
    Macut D; Bjekić-Macut J; Livadas S; Stanojlović O; Hrnčić D; Rašić-Marković A; Milutinović DV; Mladenović V; Andrić Z
    Curr Pharm Des; 2018; 24(38):4593-4597. PubMed ID: 30652641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration.
    Kim SE; Min JS; Lee S; Lee DY; Choi D
    Sci Rep; 2023 Sep; 13(1):15461. PubMed ID: 37726372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.
    Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Lonardo A
    Adv Ther; 2017 Jun; 34(6):1291-1326. PubMed ID: 28526997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and polycystic ovary syndrome.
    Vassilatou E
    World J Gastroenterol; 2014 Jul; 20(26):8351-63. PubMed ID: 25024594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.
    Rocha ALL; Faria LC; Guimarães TCM; Moreira GV; Cândido AL; Couto CA; Reis FM
    J Endocrinol Invest; 2017 Dec; 40(12):1279-1288. PubMed ID: 28612285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease and dyslipidemia: An update.
    Katsiki N; Mikhailidis DP; Mantzoros CS
    Metabolism; 2016 Aug; 65(8):1109-23. PubMed ID: 27237577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease in polycystic ovarian syndrome in Indian women.
    Siwatch S; Singh V; Dhaliwal LK; Kumari S; Singh K
    J Obstet Gynaecol; 2022 Jul; 42(5):957-961. PubMed ID: 34689689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women.
    Molina-Molina E; Furtado GE; Jones JG; Portincasa P; Vieira-Pedrosa A; Teixeira AM; Barros MP; Bachi ALL; Sardão VA
    Eur J Clin Invest; 2022 Mar; 52(3):e13731. PubMed ID: 34890043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Asfari MM; Sarmini MT; Baidoun F; Al-Khadra Y; Ezzaizi Y; Dasarathy S; McCullough A
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32784205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic manifestations of women with polycystic ovary syndrome.
    Chen MJ; Ho HN
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():119-128. PubMed ID: 27107966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peculiarities of metabolic syndrome and nonalcogolic fatty liver disease in menopausal women].
    Antelava NA; Antelava AV; Gongadze MV; Okudzhava MV; Pachkoriia KZ; Gogolauri MI
    Georgian Med News; 2012 Jul; (208-209):16-23. PubMed ID: 22899406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.
    Gutierrez-Grobe Y; Ponciano-Rodríguez G; Ramos MH; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2010; 9(4):402-9. PubMed ID: 21057159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
    Fujii H; Imajo K; Yoneda M; Nakahara T; Hyogo H; Takahashi H; Hara T; Tanaka S; Sumida Y; Eguchi Y; Chayama K; Nakajima A; Nishimoto N; Kawada N;
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1390-1395. PubMed ID: 30600551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease.
    Macut D; Božić-Antić I; Bjekić-Macut J; Tziomalos K
    Eur J Endocrinol; 2017 Sep; 177(3):R145-R158. PubMed ID: 28694246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.